---
accession : E-GEOD-18494
platform  : A-GEOD-9419
pathway   : Hypoxia
cells     : HepG2 hepatoma cell line
treatment : 0.5% Oxygen
effect    : activating
hours     : 4

control   :
    - GSM460669 1
    - GSM460670 1
    - GSM460671 1
treatment :
    - GSM460672 1
    - GSM460673 1
    - GSM460674 1

---
accession : E-GEOD-18494
platform  : A-GEOD-9419
pathway   : Hypoxia
cells     : HepG2 hepatoma cell line
treatment : 0.5% Oxygen
effect    : activating
hours     : 8

control   :
    - GSM460669 1
    - GSM460670 1
    - GSM460671 1
treatment :
    - GSM460675 1
    - GSM460676 1
    - GSM460677 1

---
accession : E-GEOD-18494
platform  : A-GEOD-9419
pathway   : Hypoxia
cells     : HepG2 hepatoma cell line
treatment : 0.5% Oxygen
effect    : activating
hours     : 12

control   :
    - GSM460669 1
    - GSM460670 1
    - GSM460671 1
treatment :
    - GSM460678 1
    - GSM460679 1
    - GSM460680 1

---
accession : E-GEOD-18494
platform  : A-GEOD-9419
pathway   : Hypoxia
cells     : U87 glioma cell line
treatment : 0.5% Oxygen
effect    : activating
hours     : 4

control   :
    - GSM460681 1
    - GSM460682 1
    - GSM460683 1
treatment :
    - GSM460684 1
    - GSM460685 1
    - GSM460686 1

---
accession : E-GEOD-18494
platform  : A-GEOD-9419
pathway   : Hypoxia
cells     : U87 glioma cell line
treatment : 0.5% Oxygen
effect    : activating
hours     : 8

control   :
    - GSM460681 1
    - GSM460682 1
    - GSM460683 1
treatment :
    - GSM460687 1
    - GSM460688 1
    - GSM460689 1

---
accession : E-GEOD-18494
platform  : A-GEOD-9419
pathway   : Hypoxia
cells     : U87 glioma cell line
treatment : 0.5% Oxygen
effect    : activating
hours     : 12

control   :
    - GSM460687 1
    - GSM460688 1
    - GSM460689 1
treatment :
    - GSM460690 1
    - GSM460691 1
    - GSM460692 1
...
